ARROWHEAD PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 955000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-03-31) |
| Status | current |
| Entity | ARROWHEAD PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:45:39.303906+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b0905a3b-507a-4d33-924e-7deea6f035a7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-023336 · Open the official SEC filing →Retrieved: 2026-08-19T08:45:39.303906+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000879407/accounts-receivable/2021-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b0905a3b-507a-4d33-924e-7deea6f035a7
History
- no predecessors — first report